Peregrine Pharmaceuticals Inc. (MM) Stock Price - PPHM

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$47.31
SMALL CAP PRO
Monthly Subscription
for only
$44.59
Canadian Level 1 + USA
Monthly Subscription
for only
$34.59
VAT not included
After Hours
Last Trade
Last: $ 4.13 ▲ 0.05 (1.23%)
Company Name Stock Ticker Symbol Market Type ISIN
Peregrine Pharmaceuticals Inc. (MM) PPHM NASDAQ Common Stock US7136615025
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.05 -1.21% 4.08 4.15 3.991 4.08 4.13 20:00:00
Bid Price Ask Price Spread Spread % News
2.15 5 2.85 57.00% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
604 108,722 $ 4.0519 $ 440.53k 231.28k 1.97 - 5.78
Last Trade Time Type Quantity Stock Price Currency
17:13:03 formt 900 $4.13 USD
Industry Sector
Biotechnology

Peregrine Pharmaceuticals Inc. (MM) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 183.99M 45.1M $ -28.16M -0.88 0.00 44.9M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ 0.00 0.00% - 7.70%

more financials information »

Peregrine Pharmaceuticals Inc. (MM) News

Latest PPHM Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical PPHM Price Data

Period † Open High Low VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Week3.834.223.673.9527136k512k298k0.256.53%
1 Month3.134.223.05613.594098k512k219k0.9530.35%
3 Months4.224.40012.853.458194k522k231k-0.14-3.32%
6 Months4.07055.782.854.134994k41M3M0.00950.23%
1 Year2.45845.781.9743.515394k189M11M1.621665.96%
3 Years10.3611.621.9745.27020189M9M-6.28-60.62%
5 Years4.9722.261.9749.16760438M13M-0.89-17.91%

Peregrine Pharmaceuticals Inc. (MM) Description

Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company developing first-in-class monoclonal antibodies for the treatment and diagnosis of cancer.


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.